GeneralConnection.com ➔ Dictionary
Dictionary Search

remicade

Synonyms

Noun

1. infliximab

2. Remicade, anti-TNF compound

Usage
Demand for Remicade Biosimilar in USA | Global Market Analysis Report - 2035 - Future Market Insights
The Remicade Biosimilars Available Now - GoodRx
How Long Does Remicade Take to Work for Ulcerative Colitis? - HealthCentral
Insurance Said His Treatment Was Covered. Then They Sent a $17,000 Bill. - New York Focus
Top anti-rheumatic products by revenue globally 2017 and 2024 - Statista
Implications of the First Liquid IV Infliximab Biosimilar - BioPharm International
Dr. Jan T. Vilcek, a Pioneer of Scientific Entrepreneurship - NYU Langone Health
Q&A: Remicade treatment weakens COVID-19 antibody response in IBD - Healio
UC Remission: Is Combination Therapy the Key? - WebMD
Remicade and pregnancy, breastfeeding, and more - Medical News Today
FDA Approves First Subcutaneous Infliximab Product - Center for Biosimilars
Inflectra, a Remicade Biosimilar, Now Available Through Medicare and Medicaid - Arthritis Foundation
Biosimilar drugs gain ground in U.S., but concerns linger about when patients can switch - statnews.com
Corticosteroid Premedication for Infliximab Remains Unnecessarily Common - AJMC
Study: Remicade effective for sarcoidosis of nerves or liver, not muscles, skin - Sarcoidosis News
Remicade Class Action Suit Settled by J&J - Anton Health
FDA SIDE EFFECTS UPDATE: Remicade and the Onset of New Autoimmune Diseases, Plus More - MedShadow Foundation
Zymfentra Launch: Here’s How to Switch to Zymfentra - GoodRx
Biosimilar Cost Cutting: Saving on Humira, Remicade, and Stelara - GoodRx
Which Biologics Treat Ulcerative Colitis (UC)? - GoodRx
J&J unfazed by falling Remicade sales - BioPharma Dive
Biosimilars of infliximab - Generics and Biosimilars Initiative
In VA Study, Many Patients Who Tried Biosimilar Infliximab Went Back to Remicade - Center for Biosimilars
Topical Application Of Infliximab (Remicade®) In The Treatment Of Corneal Caustication - ARVO Journals
University of North Carolina Study Finds Infliximab Biosimilars Comparable to Remicade in Gastroenterology and Rheumatology Clinics - Managed Healthcare Executive
J&J's Stelara clinches ulcerative colitis nod to back up declining Remicade - Fierce Pharma
FDA Approves Amgen's AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab) - Amgen
FLIXABI®, an Infliximab Biosimilar Candidate Referencing Remicade®, Receives Positive CHMP Opinion - Biogen
One of the world’s blockbuster drugs might not exist if its research hadn't flopped in a major way - Business Insider
Treating IBD with Humira, Remicade May Increase Risk of Kidney Damage: Study - AboutLawsuits.com
FTC probing J&J on Remicade, as biosimilar market remains muted - BioPharma Dive
J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit - Fierce Pharma
Which Biologic Is Best for Uveitis in Behcet’s Disease? What a New Study Found - CreakyJoints
Mass spectrometry comparison of Remicade and Remsima - Generics and Biosimilars Initiative
FDA Panel Endorses Remicade Biosimilar, a First for Arthritis - Arthritis Foundation
J&J keeping Remicade biosimilars at bay through price drops - BioProcess International
Zymfentra, a Subcutaneous Formulation of Infliximab, Approved for IBD - Medical Professionals Reference
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars (rerun) - Drug Channels
Comparison of WAC of Remicade vs biosimilars in the U.S. as of Q1 2026 - Statista
Crohn's disease medication: What if they stop working? - Medical News Today
J&J Settles Pfizer's Antitrust Suit Over Remicade Biosimilar - Law360
Development of Anti-Drug Antibodies to Infliximab (Remicade®) and Adalimumab (Humira®) in Patients With Crohn’s Disease - 2 Minute Medicine
Johnson & Johnson Loses Remicade Patent in Appeal Ruling - Bloomberg.com
FDA approves Avsola, fourth Remicade biosimilar - Healio
Pfizer is taking its fight with J&J over a blockbuster drug to court - Business Insider
How did Johnson & Johnson beat back Remicade's biosim? Call it the art of the deal - Fierce Pharma
Pfizer Alleges J&J Thwarted Competition to Remicade, in Legal Test of Biotech-Drug Copies - WSJ
Remicade, Stelara have similar speed of onset in Crohn’s - Healio
Johnson & Johnson falls short in a Remicade patent case as star drug slips in Q4 - Fierce Pharma
Johnson & Johnson's Stelara, Tremfya step up in Q4 as Remicade's decline speeds - Fierce Pharma
Pfizer Resolves Antitrust Lawsuit With J&J Over Remicade - Center for Biosimilars
J&J: Remicade holding up better than expected - BioPharma Dive
Merck lowers cost of Remicade in UK as biosimilars enter market - BioPharma Dive
J&J boasted about defending Remicade from biosims. Now it's under FTC investigation - Fierce Pharma
Remicade copy clears FDA, becomes second biosim to win approval in U.S. - BioPharma Dive
Study: Many Ankylosing Spondylitis Patients Who Stop Taking Infliximab (Remicade) Wind Up Relapsing - CreakyJoints
Should I Switch My Rheumatoid Arthritis Meds? A Patient Weighs the Pros and Cons - CreakyJoints
J&J braces for biosim attack after losing last-ditch Remicade patent fight - Fierce Pharma
FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union - Biogen
Pfizer accuses Johnson & Johnson of 'anticompetitive practices' in lawsuit - USA Today
Remicade Biosimilar Market to Reach USD 4.01 Billion By 2035 At a 5.4% CAGR, Driven By Rising Demand For Cost-Effective Autoimmune Treatments | FMI - Yahoo Finance
What Happens When an Anti-TNF Fails for RA - Arthritis Foundation
Switching Between Biologics in Inflammatory Bowel Disease - HCPLive
Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval - Reuters
As Johnson & Johnson holds off U.S. biosims, Remicade's European market share falls to 50%: report - Fierce Pharma
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars - Drug Channels
Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease - NEJM Evidence
Fourty Six Week Efficacy and Safety Results From the Remicade European Study for Chronic Uveitis (RESCU) | IOVS - ARVO Journals
Second biosimilar of Remicade approved in the US, but J&J not rattled - BioPharma Dive
Treating IBD During Pregnancy - Johns Hopkins Medicine
Merck undercuts Pfizer on Remicade biosimilar price - BioPharma Dive
Want to Switch Back to a Biologic IBD Drug After Taking a Biosimilar? New Study Says It's Safe - CreakyJoints
Celltrion Wins FDA Approval for First Subcutaneous Version of IBD Drug Infliximab - BioSpace
Celltrion taps Intract Pharma to develop world's first oral Remicade biosimilar - Fierce Pharma
FDA OK’s new Remicade copycat but no launch planned - BioPharma Dive
The Medical Minute: Biosimilars for your IBD? Nothing to fear here! - Penn State Health News
Anti-inflammatory drugs did not speed COVID-19 recovery but prevented deaths - WashU Medicine
J&J abandons Remicade patent fight against Samsung and its Renflexis biosim - Fierce Pharma
The Man Who Discovered Remicade Is All for Biosimilars - Business Insider
Top stories in gastroenterology: Ibsrela improves symptoms of IBS subtype, Remicade best for biologic-naive ulcerative colitis - Healio
Lack of Interchangeable Biosimilars Keeps J&J in the Infliximab Game - BioProcess International
Pfizer, Johnson & Johnson Settle Antitrust Suit Over Remicade - Bloomberg Law News
Comparison ASP of Remicade vs biosimilars in the U.S. Q1 2026 - Statista
J&J says ready to fend off Remicade competitor - pharmaphorum
Remicade (infliximab) antitrust $25M class action settlement - Class Action Lawsuits
Celltrion submits FDA filing for biosimilar Remicade - BioPharma Dive
Celltrion taps Lonza to produce some of its Remicade biosimilar - BioPharma Dive
FDA approves infliximab biosimilar Ixifi for all of Remicade’s indications - MDEdge
With its Remicade biosimilar stymied by the brand, Pfizer sues Johnson & Johnson for 'anticompetitive' dealmaking - Fierce Pharma
Remicade Lawsuits - AboutLawsuits.com
Pfizer sues J&J over Remicade contracts - BioPharma Dive
FDA Approves First Subcutaneous Infliximab for IBD - Managed Healthcare Executive
When Patients Develop Antibodies to TNF Inhibitors - MedCentral
Merck Announces US Launch of Biosimilar Infliximab Renflexis - Center for Biosimilars
Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed terms - Fierce Pharma
Big deal for biosims? Major French hospital group opts for Hospira’s Remicade copy - BioPharma Dive
Is It Time to Embrace an Alternative to Anti-TNF Meds for Treating Inflammatory Bowel Disease? - CreakyJoints
What’s It Like Having COVID When You’re Immunocompromised — and What I’m Still Worried About - CreakyJoints
Weight Gain on Infliximab Tied to Sex, Crohn Disease, and Disease Severity - Gastroenterology Advisor
FDA staff sounds encouraging note on Celltrion’s biosim of J&J blockbuster Remicade - BioPharma Dive
Foreign Language Equivalents
Foreign Language Equivalents of 'remicade'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
remicad,   remicadw,   remciade,   remicadee,   remicde,   rrmicade,   remicaade,   rremicade,   emicade,   remicsde,   rmicade,   remicaed,   remiicade,   rwmicade,   remocade,   remiccade,   remcade,   remucade,   ermicade,   remiade,   reemicade,   remicadr,   rmeicade,   remmicade,   temicade,   reimcade,   remicdae,   remiacde,   renicade,   re,icade,   reicade,   remicase,   remivade,   remicae,   eemicade,   remicadde,   remicafe,   remixade
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z